Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
about
Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the LiteratureEfficacy of Addition of Antiangiogenic Agents to Taxanes-Containing Chemotherapy in Advanced Nonsmall-Cell Lung Cancer: A Meta-Analysis and Systemic ReviewActivation of angiogenesis differs strongly between pulmonary carcinoids and neuroendocrine carinomas and is crucial for carcinoid tumourgenesis.Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosisInterleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.Distinct patterns of angiogenic factor expression as a predictive factor of response to chemotherapy in stage IIIA non-small-cell lung cancer patients.IL-17 Promotes Angiogenic Factors IL-6, IL-8, and Vegf Production via Stat1 in Lung Adenocarcinoma.Focus on Nintedanib in NSCLC and Other TumorsEfficacy of motesanib diphosphate in non-small-cell lung cancer.Nintedanib: A Review of Its Use as Second-Line Treatment in Adults with Advanced Non-Small Cell Lung Cancer of Adenocarcinoma Histology.Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.Platelet derived growth factor inhibitors: A potential therapeutic approach for ocular neovascularization.Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?Vascular Endothelial Growth Factor A Regulates the Secretion of Different Angiogenic Factors in Lung Cancer Cells.Efficacy of targeted agents in the treatment of elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis.Combined Ang-2 and VEGF serum levels: holding hands as a new integral biomarker in non-small-cell lung cancers.ARF: a versatile DNA damage response ally at the crossroads of development and tumorigenesis.Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.Designing Fcabs: well-expressed and stable high affinity antigen-binding Fc fragments.Effects of nintedanib on the microvascular architecture in a lung fibrosis model.Benzophenone-3 increases metastasis potential in lung cancer cells via epithelial to mesenchymal transition.Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy.Nintedanib inhibits growth of human prostate carcinoma cells by modulating both cell cycle and angiogenesis regulators.The Efficacy and Toxicity of Gefitinib in Treating Non-small Cell Lung Cancer: A Meta-analysis of 19 Randomized Clinical Trials.SOX5 induces lung adenocarcinoma angiogenesis by inducing the expression of VEGF through STAT3 signaling
P2860
Q26766244-A25EE4AF-96A4-4205-8E79-74E421D3E849Q26801118-B0C08355-B447-495D-9125-F35119CC7FD5Q33789403-9D9D9337-FBA0-4DEB-B405-D59C1042AD1CQ35558781-3B8A4763-B9E4-4ED2-AF76-5C9C97139633Q36485477-1B03A110-D0D8-4970-AE4F-4F02DD9DBD57Q37288259-EDBAF937-E364-4278-A1F1-17A5137CE062Q37397237-93E6CD3C-E1E3-4631-8D29-F5A880FBCE36Q37512962-CD45B56C-DDE6-4251-9420-9EE7B64233DCQ38230556-C8151AF4-3333-4FAD-A867-E5111197A5C7Q38430583-D676B261-D467-454F-99A3-5B837A36161DQ38498207-A7452250-130B-4288-9334-47688CE0A274Q38639664-605948FB-C2FA-4957-8836-524B449DAB3DQ38763633-46917222-6995-48F2-AAC1-A600223CC1EEQ38821641-7FA97FD5-51A5-4CAF-A1D3-748F1701B117Q38930558-BA5E496E-8F4A-48B6-87CC-444A04910CEFQ38943409-405A264D-9409-4344-918E-D9DF83697937Q42139522-5B3B15E7-5E73-47D8-9B02-2B193AD82DDAQ47107773-543BA599-2FFB-41BC-96C8-D52AECA8A9F2Q47597969-7B37F680-B596-4206-90F7-FD9721D57DE2Q47952164-4CE5504B-DF9F-4A26-BB33-8FDB502C7343Q51354400-91C40891-FCBF-416C-839A-9004DE1C9858Q54963997-24ED0D5B-BA8A-4EE9-9B0D-C871F73880FEQ55332470-92A6AD25-A130-4D23-8209-256C1CF843E3Q55409671-3490A9C3-EAB9-48A3-A002-7FA13E26453CQ58750993-868F2440-E063-4E8D-91E1-D831BE7870A2
P2860
Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
@ast
Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
@en
Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
@nl
type
label
Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
@ast
Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
@en
Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
@nl
prefLabel
Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
@ast
Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
@en
Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
@nl
P3181
P1476
Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
@en
P2093
P3181
P356
10.1183/09059180.00008913
P407
P577
2014-03-01T00:00:00Z